AbbVie Inc. (ABBV)
A+
Pipeline Grade
Financial Position (from SEC Filings)
$9,391.0M
Cash & Equivalents
$3,829.0M
Quarterly Burn Rate
$380,567M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (62 Assets)
| Drug | Phase | Indications |
|---|---|---|
|
MILNACIPRAN HYDROCHLORIDE
SAVELLA |
APPROVED | — |
|
CITALOPRAM HYDROBROMIDE
CELEXA |
APPROVED | — |
|
BRIMONIDINE TARTRATE
ALPHAGAN P |
APPROVED | — |
|
UBROGEPANT
UBRELVY |
APPROVED | — |
|
GATIFLOXACIN
ZYMAXID |
APPROVED | — |
|
PARICALCITOL
ZEMPLAR |
APPROVED | — |
|
FOSCARBIDOPA, FOSLEVODOPA
VYALEV |
APPROVED | — |
|
VILAZODONE HYDROCHLORIDE
VIIBRYD |
APPROVED | — |
|
AVIBACTAM SODIUM, AZTREONAM
EMBLAVEO |
APPROVED | — |
|
LEVOTHYROXINE SODIUM
SYNTHROID |
APPROVED | — |
|
FLUOROMETHOLONE
FML |
APPROVED | — |
|
AVIBACTAM SODIUM, CEFTAZIDIME
AVYCAZ |
APPROVED | — |
|
ASENAPINE MALEATE
SAPHRIS |
APPROVED | — |
|
ELAGOLIX SODIUM
ORILISSA |
APPROVED | — |
|
PANCRELIPASE (AMYLASE, LIPASE, PROTEASE)
CREON |
APPROVED | — |
|
ATOGEPANT
QULIPTA |
APPROVED | — |
|
LEVOMILNACIPRAN HYDROCHLORIDE
FETZIMA |
APPROVED | — |
|
DALBAVANCIN HYDROCHLORIDE
DALVANCE |
APPROVED | — |
|
CEFTAROLINE FOSAMIL
TEFLARO |
APPROVED | — |
|
DEOXYCHOLIC ACID
KYBELLA |
APPROVED | — |
|
GLECAPREVIR, PIBRENTASVIR
MAVYRET |
APPROVED | — |
|
CARIPRAZINE HYDROCHLORIDE
VRAYLAR |
APPROVED | — |
|
SEVOFLURANE
ULTANE |
APPROVED | — |
|
ELUXADOLINE
VIBERZI |
APPROVED | — |
|
LOPINAVIR, RITONAVIR
KALETRA |
APPROVED | — |
|
KETOROLAC TROMETHAMINE
ACULAR LS |
APPROVED | — |
|
UPADACITINIB
RINVOQ LQ |
APPROVED | — |
|
OXYBUTYNIN CHLORIDE
GELNIQUE |
NDA | — |
|
SILODOSIN
RAPAFLO |
NDA | — |
|
CLARITHROMYCIN
BIAXIN |
NDA | — |
|
EFLORNITHINE HYDROCHLORIDE
VANIQA |
NDA | — |
|
MIVACURIUM CHLORIDE
MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER |
NDA | — |
|
CHOLINE FENOFIBRATE
TRILIPIX |
NDA | — |
|
IOPAMIDOL
IOPAMIDOL-300 |
NDA | — |
|
CEFDINIR
OMNICEF |
NDA | — |
|
HEXOCYCLIUM METHYLSULFATE
TRAL |
NDA | — |
|
PROGESTERONE
CRINONE |
NDA | — |
|
DARIFENACIN HYDROBROMIDE
ENABLEX |
NDA | — |
|
TRIMETHADIONE
TRIDIONE |
NDA | — |
|
DASABUVIR SODIUM, OMBITASVIR, PARITAPREVIR, RITONAVIR
VIEKIRA XR |
NDA | Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Advanced or Metastatic Non-Small Cell Lung Cancer, Advanced Parkinson's Disease, Advanced Solid Tumors, Advanced Solid Tumors Cancer, Aggressive Diffuse Large B-cell Lymphoma, ALL, Alzheimer's Disease, Ankylosing Spondylitis, Atherosclerosis, Atopic Dermatitis, Autism Spectrum Disorder, B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, Breast Cancer, Breast Neoplasms, Cancer, Chronic Hepatitis C, Chronic Hepatitis C (CHC), Chronic Hepatitis C Infection, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia (CLL), Chronic Myeloid Leukemia, Classic Follicular Lymphoma, Colon Cancer, Colorectal Carcinoma, Compensated Cirrhosis and Non-cirrhotics, Crohn Disease, Crohn's Disease, Cystic Fibrosis, Cystic Fibrosis (CF), Diffuse Large B-Cell Lymphoma, Drug Monitoring, Dyskinesias, Episodic Migraine, Follicular Lymphoma (FL) Grade 3B, Gastric Cancer, Generalized Anxiety Disorder (GAD), Glioblastoma Multiforme, HCV, Head and Neck |
|
OMBITASVIR, PARITAPREVIR, RITONAVIR
TECHNIVIE |
NDA | — |
|
ESCITALOPRAM OXALATE
LEXAPRO |
NDA | — |
|
METHYCLOTHIAZIDE
ENDURON |
NDA | — |
|
NIACIN
NIASPAN |
NDA | — |
|
NEBIVOLOL HYDROCHLORIDE, VALSARTAN
BYVALSON |
NDA | — |
|
BIPERIDEN HYDROCHLORIDE
AKINETON |
NDA | — |
|
PHENACEMIDE
PHENURONE |
NDA | — |
|
TRANDOLAPRIL, VERAPAMIL HYDROCHLORIDE
TARKA |
NDA | — |
|
CARTEOLOL HYDROCHLORIDE
CARTROL |
NDA | — |
|
ATROPINE
ATROPINE |
NDA | — |
|
VALPROATE SODIUM
DEPACON |
NDA | — |
|
METHARBITAL
GEMONIL |
NDA | — |
|
MESALAMINE
ASACOL HD |
NDA | — |
|
TRANDOLAPRIL
MAVIK |
NDA | — |
|
DESERPIDINE
HARMONYL |
NDA | — |
|
MEMANTINE HYDROCHLORIDE
NAMENDA |
NDA | — |
|
ISOPROTERENOL SULFATE
NORISODRINE |
NDA | — |
|
ALCAFTADINE
LASTACAFT |
NDA | — |
|
OXYBUTYNIN
OXYTROL FOR WOMEN |
NDA | — |
|
PROTEIN HYDROLYSATE
AMINOSOL 5% |
NDA | — |
|
BIPERIDEN LACTATE
AKINETON |
NDA | — |
|
VALPROIC ACID
DEPAKENE |
NDA | — |
Upcoming Catalysts
No upcoming catalysts detected for this company.